# Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects

> **NCT02952547** · PHASE1 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 52 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Co-administration of DWC20155 and DWC20156
- **DRUG:** DWJ1366 Tab.

## Key facts

- **NCT ID:** NCT02952547
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-30
- **Primary completion:** 2016-11-26
- **Final completion:** 2017-01-10
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2017-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02952547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02952547, "Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02952547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*